Skip to main content
OpenTrials
Completed

NCT Number: NCT04838990

TELEMS: Feasibility of Remote Patient Visits in MS

This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Nervous System Diseases

Age range

16 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of Vienna

Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • confirmed diagnosis of any type of MS
  • own a phone/smartphone/computer
  • informed consent

Exclusion criteria

  • language barriers

Treatment and study plan

EDSS

Other

Neurological Exam - EDSS (Expanded Disability Status Scale)

Discussion of symptoms, Patient reported outcome (MSIS)

Other

Patients will be asked about their wellbeing

Primary outcomes

  1. TMPQ

    Time frame: 1 week after intervention

    Telemedicine Perception questionnaire (17-85, higher scores are better)

Secondary outcomes

  1. PPSM

    Time frame: 1 week after intervention

    Patient and Physician Satisfaction with monitoring (6-30, higher scores are better)

Other outcomes

  1. Ancillary Analyses

    Time frame: immediately after the intervention

    Subgroup analyses comparing scores on the TMPQ above and below the median (Telemedicine Perception questionnaire, 17-85 points, higher scores are better) with clinical characteristics (EDSS and MSIS and Age)

  2. Empirical Questionnaire

    Time frame: 1 week after intervention

    Participants are given an opportunity to openly provide feedback

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

TELE MS RCT: A Randomized Controlled Trial to Evaluate Feasibility of Remote Patient Visits in People With Multiple Sclerosis

Acronym: TELEMSRCT

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Apr 9, 2021
Registry last updated
Jan 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.